Speaking Companies

Accenture
Access BridgeGap Ventures
Antares Pharma, Inc.
Avila Therapeutics
Blueprint Medicines
Bracewell and Giuliani LLP
Brinks Hofer Gilson & Lione
Celgene Corporation
Centers for Therapeutic Innovation (CTI)
Cubist Pharmaceuticals, Inc.
Dicerna Pharmaceuticals
EMC Corp.
Epizyme
everythingHEALTH, LLC
Foley Hoag LLP
Forest Laboratories
Fox Rothschild LLP
Genzyme
Greenblum & Bernstein
Harvard Medical School Office
Health Advances
Hoffmann-La Roche Inc.
Idec
Infinity Pharmaceuticals, Inc.
Intel Corporation
Johnson & Johnson Healthcare Products
Juvenile Diabetes Research Foundation
Massachusetts Institute of Technology
Merck
MIT
Mount Sinai School of Medicine
Nissen Consulting Group, LLC
Paladin Labs Inc.
Partners Research Ventures and Licensing
Pfizer
Pluritas, LLC
Population Council
Puretech Ventures
RoyaltyStat
Sidley Austin
Sigma-Aldrich
Sohn Health Strategies
Stanford University
Sutro Biopharma
Susan B. Levy Consulting
Trout Creek Consulting, LLC
Wiggin and Dana LLP
WilmerHale
ZenithBIO

Registration Info

Registration Form
Registration Fees

Registration for the Spring Meeting is available in person at the LES Registration Desk at the Hyatt Regency Boston. Hours are Tuesday May 15 8:00 a.m. to 7:00 p.m.; Wednesday May 16 7:30 a.m. - 5:00 p.m.; Thursday May 17 7:30 a.m. to 11:00 a.m.

CONTACT

meetings@les.org
703-836-3106

DOWNLOADABLE BROCHURE

LES 2012 Spring Meeting Brochure